Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Testosterone's effects on COVID-19 are unclear and need more research.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Testosterone may influence COVID-19 severity and outcomes.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Matriptase is highly active in hair follicles and sebaceous glands, especially during hair growth phases.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

COVID-19 may worsen with androgens; anti-androgen drugs could help.